Pre/Post Influenza Vaccine Sera Panels

Added: Mar 17, 2014 11:32 am The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) has a requirement to acquire pre and post influenza vaccine sera panels from pediatric, adult, and elderly U.S. populations.

The pre and post influenza vaccination sera must be collected from healthy individuals that fall into three age categories: 1) pediatric; 6 to 36 months of age who have not previously received an influenza  vaccine and who have not had a laboratory confirmed case of influenza  2) adult; 18 to 49 years of age, and 3) elderly; 65 years of age or older and community dwelling.
 

The offeror must provide sera from 60 participants for each age category. The volume of sera to be provided is 1) pediatric= 2.5 ml of both pre and post vaccine sera 2) adult= 10 ml of pre vaccine sera and 10 ml of post vaccine from 30 participants and 50 ml of post vaccine from 30 participants and 3) 10 ml of both pre and post vaccine sera.

The agency is seeking small business vendors who possess and will provide all labor, facilities, materials [to include influenza vaccine], supplies and equipment necessary to:1) reach the desired study populations, 2) obtain IRB clearance for the study so sera can be collected and shipped to the CDControl in Atlanta during the 2014/2015 U.S. influenza season and 3) possessing past experience performing research studies of similar scope.

Small business entities who believe themselves capable of fullfilling the requirement and possessing the above stated qualifications are invited to provide a statement of capabilities to the Contracting Office no later than 5:00 PM EDT, on Tuesday 25 March 2014.  Information obtained from responses will be used to determine if there are any small business entities that can execute the project to an extent consistent with the Government's interest and at a fair and reasonable price.